小时 | 讲者 | 演讲标题 | 讲稿摘要 | 数字 |
20:30 | Introduction | 111630 | ||
20:35 | Part 1 - Market analysis | 111631 | ||
20:35 | Chinese and APAC market carrying the torch of medical aesthetics recovery post-Covid | 111632 | ||
20:45 | Medical aesthetic market trends and competitive strategies | 111633 | ||
20:55 | Part 2 - Aesthetic Medicine Roundtable | 111634 | ||
21:25 | CEO, Sinclair China | 111636 | ||
21:25 | Executive Director, Haohai | 112211 | ||
21:25 | CEO, HTL Biotechnology | 111637 | ||
21:25 | R&D Director, China National Biotec Group (CNBG) | 111635 | ||
21:25 | Q&A with the audience | 111639 | ||
21:40 | Part 3 - Medical Dermatology Roundtable | 111640 | ||
22:10 | CEO, Hyphens Pharma | 111641 | ||
22:10 | Executive Director, HighLight Capital - PhD | 111643 | ||
22:10 | CEO, Maruho | 112210 | ||
22:10 | CEO, Technoderma Medicines | 111642 | ||
22:10 | CEO, Profex Inc | 111644 | ||
22:10 | Q&A with the audience | 111645 | ||
22:25 | Conclusion | 111646 | ||